IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$10.6M
3
+$7.73M
4
SAGE
Sage Therapeutics
SAGE
+$6.1M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$5.3M

Top Sells

1
+$12.7M
2
+$11.3M
3
+$11.1M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.76M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$17.6M 8.76%
978,783
+929,684
2
$14.3M 7.13%
2,131,147
+76,545
3
$13.6M 6.81%
+231,181
4
$9.11M 4.55%
+492,275
5
$8.98M 4.48%
850,134
-168,193
6
$8.92M 4.45%
317,476
-220,482
7
$7.86M 3.92%
855,616
-523,806
8
$7.31M 3.65%
610,407
-389,980
9
$6.32M 3.16%
699,440
+107,317
10
$6.27M 3.13%
72,859
-67,953
11
$6.18M 3.08%
+157,805
12
$6.03M 3.01%
472,054
-425,305
13
$5.79M 2.89%
160,486
-78,955
14
$5.33M 2.66%
904,119
+204,119
15
$5.32M 2.65%
+325,000
16
$5.03M 2.51%
+178,100
17
$4.62M 2.31%
138,277
-1,166
18
$4.59M 2.29%
74,219
-85,897
19
$4.53M 2.26%
+811,700
20
$3.78M 1.89%
3,178,825
+1,498,273
21
$3.51M 1.75%
+350,000
22
$3.48M 1.74%
+450,406
23
$3.32M 1.66%
+5,714
24
$3.17M 1.58%
+96,462
25
$3.13M 1.56%
479,383
-404,625
1
2 3 4 5